id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
list | ner_tags
list |
|---|---|---|---|---|---|
NCT02215096
|
,32:74:treatment
|
Completed at least 12 weeks of prior continuous therapy with enzalutamide
| 1
|
[
"Completed",
"at",
"least",
"12",
"weeks",
"of",
"prior",
"continuous",
"therapy",
"with",
"enzalutamide"
] |
[
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1
] |
NCT03000257
|
20:36:chronic_disease,38:65:treatment,67:95:cancer,97:124:treatment,160:172:chronic_disease
|
History of primary immunodeficiency, bone marrow transplantation, chronic lymphocytic leukemia, solid organ transplantation, or previous clinical diagnosis of tuberculosis
| 1
|
[
"History",
"of",
"primary",
"immunodeficiency",
",",
"bone",
"marrow",
"transplantation",
",",
"chronic",
"lymphocytic",
"leukemia",
",",
"solid",
"organ",
"transplantation",
",",
"or",
"previous",
"clinical",
"diagnosis",
"of",
"tuberculosis"
] |
[
0,
0,
0,
2,
0,
1,
1,
1,
0,
3,
3,
3,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
2
] |
NCT01774487
|
21:43:treatment
|
Infants receiving a Kasai portoenterostomy at another institution
| 1
|
[
"Infants",
"receiving",
"a",
"Kasai",
"portoenterostomy",
"at",
"another",
"institution"
] |
[
0,
0,
0,
1,
1,
0,
0,
0
] |
NCT02560623
|
34:58:chronic_disease,60:69:chronic_disease,73:97:chronic_disease
|
Patients with current history of eosinophilic esophagitis, achalasia or uninvestigated dysphagia
| 1
|
[
"Patients",
"with",
"current",
"history",
"of",
"eosinophilic",
"esophagitis",
",",
"achalasia",
"or",
"uninvestigated",
"dysphagia"
] |
[
0,
0,
0,
0,
0,
2,
2,
0,
2,
0,
2,
2
] |
NCT03176979
|
17:30:cancer
|
Newly diagnosed breast cancer patients
| 1
|
[
"Newly",
"diagnosed",
"breast",
"cancer",
"patients"
] |
[
0,
0,
3,
3,
0
] |
NCT02565498
|
9:21:treatment
|
Planned chemotherapy for (neo)adjuvant treatment
| 1
|
[
"Planned",
"chemotherapy",
"for",
"(",
"neo",
")",
"adjuvant",
"treatment"
] |
[
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02985554
|
15:31:chronic_disease
|
patients with Gilbert Syndrome
| 1
|
[
"patients",
"with",
"Gilbert",
"Syndrome"
] |
[
0,
0,
2,
2
] |
NCT02385110
|
47:50:chronic_disease,
|
We have seen an increasing number of cases of HLH at our institution over the last 2 years partly due to referrals and partly due to better understanding of the disease through discussions with our collaborators Dr Kenneth McClain and Dr Carl Allen at TCH (experts in pediatric HLH)
| 1
|
[
"We",
"have",
"seen",
"an",
"increasing",
"number",
"of",
"cases",
"of",
"HLH",
"at",
"our",
"institution",
"over",
"the",
"last",
"2",
"years",
"partly",
"due",
"to",
"referrals",
"and",
"partly",
"due",
"to",
"better",
"understanding",
"of",
"the",
"disease",
"through",
"discussions",
"with",
"our",
"collaborators",
"Dr",
"Kenneth",
"McClain",
"and",
"Dr",
"Carl",
"Allen",
"at",
"TCH",
"(",
"experts",
"in",
"pediatric",
"HLH",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03072238
|
51:67:chronic_disease,73:76:chronic_disease,102:129:treatment
|
Immunocompromised status because of current known active infection with HIV or because of the use of immunosuppressive therapies for other conditions
| 1
|
[
"Immunocompromised",
"status",
"because",
"of",
"current",
"known",
"active",
"infection",
"with",
"HIV",
"or",
"because",
"of",
"the",
"use",
"of",
"immunosuppressive",
"therapies",
"for",
"other",
"conditions"
] |
[
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0
] |
NCT02530034
|
66:81:treatment,93:103:treatment,,150:166:treatment,,197:216:treatment
|
In the absence of rapidly progressing disease, the interval from prior treatment to time of study drug administration should be at least 2 weeks for cytotoxic agents, or at least 5 half-lives for noncytotoxic agents
| 1
|
[
"In",
"the",
"absence",
"of",
"rapidly",
"progressing",
"disease",
",",
"the",
"interval",
"from",
"prior",
"treatment",
"to",
"time",
"of",
"study",
"drug",
"administration",
"should",
"be",
"at",
"least",
"2",
"weeks",
"for",
"cytotoxic",
"agents",
",",
"or",
"at",
"least",
"5",
"half-lives",
"for",
"noncytotoxic",
"agents"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02469129
|
22:36:treatment,
|
Unable to lie in the PET/CT scanner for the time required for scanning, up to 1 hour and 15 min at a time and possibly with arms raised above the head for lung imaging
| 1
|
[
"Unable",
"to",
"lie",
"in",
"the",
"PET/CT",
"scanner",
"for",
"the",
"time",
"required",
"for",
"scanning",
",",
"up",
"to",
"1",
"hour",
"and",
"15",
"min",
"at",
"a",
"time",
"and",
"possibly",
"with",
"arms",
"raised",
"above",
"the",
"head",
"for",
"lung",
"imaging"
] |
[
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02043548
|
36:55:chronic_disease,57:62:chronic_disease,64:70:chronic_disease,72:85:chronic_disease,95:105:chronic_disease,136:148:chronic_disease,153:183:chronic_disease,185:202:chronic_disease,208:221:chronic_disease
|
Known active current or history of recurrent bacterial, viral, fungal, mycobacterial or other infections (including but not limited to tuberculosis and atypical mycobacterial disease, Hepatitis B and C, and herpes zoster
| 1
|
[
"Known",
"active",
"current",
"or",
"history",
"of",
"recurrent",
"bacterial",
",",
"viral",
",",
"fungal",
",",
"mycobacterial",
"or",
"other",
"infections",
"(",
"including",
"but",
"not",
"limited",
"to",
"tuberculosis",
"and",
"atypical",
"mycobacterial",
"disease",
",",
"Hepatitis",
"B",
"and",
"C",
",",
"and",
"herpes",
"zoster"
] |
[
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
0,
2,
0,
2,
0,
0,
2,
0,
0,
0,
0,
0,
0,
2,
0,
2,
2,
2,
0,
2,
2,
2,
2,
0,
0,
2,
2
] |
NCT02527421
|
,75:90:treatment
|
Use within 30 days prior to the Screening Visit of any product containing corticosteroids
| 1
|
[
"Use",
"within",
"30",
"days",
"prior",
"to",
"the",
"Screening",
"Visit",
"of",
"any",
"product",
"containing",
"corticosteroids"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01774019
|
1:8:treatment,
|
Surgery intent within 4 weeks
| 1
|
[
"Surgery",
"intent",
"within",
"4",
"weeks"
] |
[
1,
0,
0,
0,
0
] |
NCT01505569
|
1:6:cancer
|
Tumor may have originated in any primary site
| 1
|
[
"Tumor",
"may",
"have",
"originated",
"in",
"any",
"primary",
"site"
] |
[
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT00632853
|
115:127:treatment
|
patients also must have met all of the eligibility criteria in the protocol prior to receiving the first cycle of chemotherapy
| 1
|
[
"patients",
"also",
"must",
"have",
"met",
"all",
"of",
"the",
"eligibility",
"criteria",
"in",
"the",
"protocol",
"prior",
"to",
"receiving",
"the",
"first",
"cycle",
"of",
"chemotherapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02132598
|
26:43:treatment
|
The subject has received radiation therapy
| 1
|
[
"The",
"subject",
"has",
"received",
"radiation",
"therapy"
] |
[
0,
0,
0,
0,
1,
1
] |
NCT02408861
|
33:53:treatment
|
The lesion being considered for palliative radiation is not a target lesion
| 1
|
[
"The",
"lesion",
"being",
"considered",
"for",
"palliative",
"radiation",
"is",
"not",
"a",
"target",
"lesion"
] |
[
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT03108950
|
32:41:chronic_disease
|
Current use of medications for psychosis
| 1
|
[
"Current",
"use",
"of",
"medications",
"for",
"psychosis"
] |
[
0,
0,
0,
0,
0,
2
] |
NCT00230607
|
49:58:treatment
|
be enrolled in the Fabry Registry and receiving Fabrazyme while lactating
| 1
|
[
"be",
"enrolled",
"in",
"the",
"Fabry",
"Registry",
"and",
"receiving",
"Fabrazyme",
"while",
"lactating"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0
] |
NCT02500407
|
1:28:treatment,,63:72:treatment,74:87:treatment
|
Treatment with radiotherapy within 2 weeks prior to the first BTCT4465A (Mosunetuzumab) administration
| 1
|
[
"Treatment",
"with",
"radiotherapy",
"within",
"2",
"weeks",
"prior",
"to",
"the",
"first",
"BTCT4465A",
"(",
"Mosunetuzumab",
")",
"administration"
] |
[
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0
] |
NCT02276456
|
240:250:cancer
|
Examples include transition of care goals to comfort care, transition of care to inpatient or outpatient hospice, or the development of complications during the hospitalization that require early follow up appointments (e.g., diagnosis of malignancy)
| 1
|
[
"Examples",
"include",
"transition",
"of",
"care",
"goals",
"to",
"comfort",
"care",
",",
"transition",
"of",
"care",
"to",
"inpatient",
"or",
"outpatient",
"hospice",
",",
"or",
"the",
"development",
"of",
"complications",
"during",
"the",
"hospitalization",
"that",
"require",
"early",
"follow",
"up",
"appointments",
"(",
"e.g.",
",",
"diagnosis",
"of",
"malignancy",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0
] |
NCT02465268
|
1:42:cancer
|
Recurrent or multifocal malignant gliomas
| 1
|
[
"Recurrent",
"or",
"multifocal",
"malignant",
"gliomas"
] |
[
3,
3,
3,
3,
3
] |
NCT01515527
|
13:37:chronic_disease
|
symptomatic congestive heart failure
| 1
|
[
"symptomatic",
"congestive",
"heart",
"failure"
] |
[
0,
2,
2,
2
] |
NCT02437370
|
18:57:cancer,65:89:cancer,124:140:cancer,218:225:treatment,,277:292:treatment,422:430:treatment,
|
Has known active central nervous system (CNS) metastases and/or carcinomatous meningitis; subjects with previously treated brain metastases may participate provided they are stable (without evidence of progression by imaging for at least four weeks prior to the first dose of trial treatment and any neurologic symptoms have returned to baseline), have no evidence of new or enlarging brain metastases, and are not using steroids for at least 7 days prior to trial treatment
| 1
|
[
"Has",
"known",
"active",
"central",
"nervous",
"system",
"(",
"CNS",
")",
"metastases",
"and/or",
"carcinomatous",
"meningitis",
";",
"subjects",
"with",
"previously",
"treated",
"brain",
"metastases",
"may",
"participate",
"provided",
"they",
"are",
"stable",
"(",
"without",
"evidence",
"of",
"progression",
"by",
"imaging",
"for",
"at",
"least",
"four",
"weeks",
"prior",
"to",
"the",
"first",
"dose",
"of",
"trial",
"treatment",
"and",
"any",
"neurologic",
"symptoms",
"have",
"returned",
"to",
"baseline",
")",
",",
"have",
"no",
"evidence",
"of",
"new",
"or",
"enlarging",
"brain",
"metastases",
",",
"and",
"are",
"not",
"using",
"steroids",
"for",
"at",
"least",
"7",
"days",
"prior",
"to",
"trial",
"treatment"
] |
[
0,
0,
0,
3,
3,
3,
3,
3,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02408861
|
1:18:treatment
|
anabolic steroids
| 1
|
[
"anabolic",
"steroids"
] |
[
1,
1
] |
NCT02169089
|
1:20:treatment
|
Oral contraceptives are disallowed
| 1
|
[
"Oral",
"contraceptives",
"are",
"disallowed"
] |
[
1,
1,
0,
0
] |
NCT02393690
|
19:22:treatment,31:57:treatment,73:85:treatment,
|
It is noted to be RAI-avid on radioactive iodine imaging (diagnostic or post-therapy whole body scans acceptable) and it measures >= 1 cm in the long axis
| 1
|
[
"It",
"is",
"noted",
"to",
"be",
"RAI-avid",
"on",
"radioactive",
"iodine",
"imaging",
"(",
"diagnostic",
"or",
"post-therapy",
"whole",
"body",
"scans",
"acceptable",
")",
"and",
"it",
"measures",
">",
"=",
"1",
"cm",
"in",
"the",
"long",
"axis"
] |
[
0,
0,
0,
0,
0,
1,
0,
1,
1,
1,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01811381
|
14:22:chronic_disease
|
diagnosis of dementia
| 1
|
[
"diagnosis",
"of",
"dementia"
] |
[
0,
0,
2
] |
NCT02567422
|
1:26:cancer
|
nasopharyngeal carcinomas
| 1
|
[
"nasopharyngeal",
"carcinomas"
] |
[
3,
3
] |
NCT02664909
|
11:42:treatment
|
undergone coronary artery bypass grafting
| 1
|
[
"undergone",
"coronary",
"artery",
"bypass",
"grafting"
] |
[
0,
1,
1,
1,
1
] |
NCT02562040
|
19:43:chronic_disease,,
|
History of severe developmental disability or Adaptive Behavior Assessment System (ABAS-3) score ≤60
| 1
|
[
"History",
"of",
"severe",
"developmental",
"disability",
"or",
"Adaptive",
"Behavior",
"Assessment",
"System",
"(",
"ABAS-3",
")",
"score",
"≤60"
] |
[
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01675154
|
1:28:chronic_disease
|
Type I hyperlipoproteinemia
| 1
|
[
"Type",
"I",
"hyperlipoproteinemia"
] |
[
2,
2,
2
] |
NCT02446886
|
39:43:allergy_name
|
Patients with known or new allergy to ACTH
| 1
|
[
"Patients",
"with",
"known",
"or",
"new",
"allergy",
"to",
"ACTH"
] |
[
0,
0,
0,
0,
0,
0,
0,
4
] |
NCT01928576
|
15:23:chronic_disease,25:49:chronic_disease,60:74:chronic_disease,85:104:treatment
|
Subjects with vitiligo, type 1 diabetes mellitus, residual hypothyroidism requiring hormone replacement, or conditions not expected to recur in the absence of an external trigger are permitted to enroll
| 1
|
[
"Subjects",
"with",
"vitiligo",
",",
"type",
"1",
"diabetes",
"mellitus",
",",
"residual",
"hypothyroidism",
"requiring",
"hormone",
"replacement",
",",
"or",
"conditions",
"not",
"expected",
"to",
"recur",
"in",
"the",
"absence",
"of",
"an",
"external",
"trigger",
"are",
"permitted",
"to",
"enroll"
] |
[
0,
0,
2,
0,
2,
2,
2,
2,
0,
0,
2,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02133898
|
1:15:treatment
|
Concurrent ECT
| 1
|
[
"Concurrent",
"ECT"
] |
[
1,
1
] |
NCT02460692
|
30:44:chronic_disease,46:53:chronic_disease,57:70:chronic_disease,72:97:chronic_disease,103:128:chronic_disease,134:140:chronic_disease,142:146:chronic_disease
|
Individuals with significant cardiovascular, hepatic or renal disease, uncontrolled hypertension, and chronic pulmonary disease (eg, asthma, COPD)
| 1
|
[
"Individuals",
"with",
"significant",
"cardiovascular",
",",
"hepatic",
"or",
"renal",
"disease",
",",
"uncontrolled",
"hypertension",
",",
"and",
"chronic",
"pulmonary",
"disease",
"(",
"eg",
",",
"asthma",
",",
"COPD",
")"
] |
[
0,
0,
0,
2,
0,
2,
0,
2,
2,
0,
2,
2,
0,
0,
2,
2,
2,
0,
0,
0,
2,
0,
2,
0
] |
NCT02798458
|
1:29:treatment
|
Endoscopic mucosal resection
| 1
|
[
"Endoscopic",
"mucosal",
"resection"
] |
[
1,
1,
1
] |
NCT02310464
|
,95:104:treatment
|
Subjects of child-bearing potential must agree to use acceptable contraceptive methods during treatment and until the end of the study
| 1
|
[
"Subjects",
"of",
"child-bearing",
"potential",
"must",
"agree",
"to",
"use",
"acceptable",
"contraceptive",
"methods",
"during",
"treatment",
"and",
"until",
"the",
"end",
"of",
"the",
"study"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02446210
|
41:44:chronic_disease
|
Exclusion criteria for individuals with SCI and Healthy Controls
| 1
|
[
"Exclusion",
"criteria",
"for",
"individuals",
"with",
"SCI",
"and",
"Healthy",
"Controls"
] |
[
0,
0,
0,
0,
0,
2,
0,
0,
0
] |
NCT02242110
|
11:29:treatment,
|
Stable on bipolar medication for at least 2 months
| 1
|
[
"Stable",
"on",
"bipolar",
"medication",
"for",
"at",
"least",
"2",
"months"
] |
[
0,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT02429830
|
32:36:chronic_disease,
|
Documented typical symptoms of GERD for longer than 6 months
| 1
|
[
"Documented",
"typical",
"symptoms",
"of",
"GERD",
"for",
"longer",
"than",
"6",
"months"
] |
[
0,
0,
0,
0,
2,
0,
0,
0,
0,
0
] |
NCT03058029
|
12:24:chronic_disease,
|
History of pancreatitis within the past 12 months
| 1
|
[
"History",
"of",
"pancreatitis",
"within",
"the",
"past",
"12",
"months"
] |
[
0,
0,
2,
0,
0,
0,
0,
0
] |
NCT03104699
|
39:61:chronic_disease
|
Clinically significant (i.e., active) cardiovascular disease
| 1
|
[
"Clinically",
"significant",
"(",
"i.e.",
",",
"active",
")",
"cardiovascular",
"disease"
] |
[
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02547662
|
7:41:chronic_disease
|
Known human immunodeficiency virus (HIV) positive
| 1
|
[
"Known",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"positive"
] |
[
0,
2,
2,
2,
2,
0,
0,
0
] |
NCT03139318
|
25:45:treatment,50:65:treatment,74:83:treatment,87:124:cancer
|
Subject is eligible for routine chemotherapy and routine surgery for the treatment of non-metastatic extremity osteosarcoma
| 1
|
[
"Subject",
"is",
"eligible",
"for",
"routine",
"chemotherapy",
"and",
"routine",
"surgery",
"for",
"the",
"treatment",
"of",
"non-metastatic",
"extremity",
"osteosarcoma"
] |
[
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
1,
0,
3,
3,
3
] |
NCT03088709
|
23:53:chronic_disease
|
Transfusion dependent myelodysplastic syndrome (MDS)
| 1
|
[
"Transfusion",
"dependent",
"myelodysplastic",
"syndrome",
"(",
"MDS",
")"
] |
[
0,
0,
2,
2,
2,
0,
0
] |
NCT01614990
|
,,14:17:chronic_disease,19:23:chronic_disease,32:36:chronic_disease,54:61:treatment
|
class III-IV CHF, AIDS, severe COPD requiring use of home O2
| 1
|
[
"class",
"III-IV",
"CHF",
",",
"AIDS",
",",
"severe",
"COPD",
"requiring",
"use",
"of",
"home",
"O2"
] |
[
0,
0,
2,
0,
2,
0,
0,
2,
0,
0,
0,
1,
1
] |
NCT03041441
|
1:9:treatment
|
sedation
| 1
|
[
"sedation"
] |
[
1
] |
NCT02277782
|
1:31:chronic_disease
|
prolonged rupture of membranes
| 1
|
[
"prolonged",
"rupture",
"of",
"membranes"
] |
[
2,
2,
2,
2
] |
NCT01827384
|
,,,224:238:treatment
|
Patients must have measurable disease, defined as at least one lesion that can be accurately measured in at least one dimension (longest diameter to be recorded) as >= 20 mm with conventional techniques or as >= 10 mm with spiral CT scan
| 1
|
[
"Patients",
"must",
"have",
"measurable",
"disease",
",",
"defined",
"as",
"at",
"least",
"one",
"lesion",
"that",
"can",
"be",
"accurately",
"measured",
"in",
"at",
"least",
"one",
"dimension",
"(",
"longest",
"diameter",
"to",
"be",
"recorded",
")",
"as",
">",
"=",
"20",
"mm",
"with",
"conventional",
"techniques",
"or",
"as",
">",
"=",
"10",
"mm",
"with",
"spiral",
"CT",
"scan"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02041936
|
1:6:cancer
|
Tumor size not measurable
| 1
|
[
"Tumor",
"size",
"not",
"measurable"
] |
[
3,
0,
0,
0
] |
NCT02656706
|
42:60:chronic_disease
|
Subjects with active, known or suspected autoimmune disease
| 1
|
[
"Subjects",
"with",
"active",
",",
"known",
"or",
"suspected",
"autoimmune",
"disease"
] |
[
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02979366
|
1:40:chronic_disease
|
Uncontrolled hepatitis B or C infection
| 1
|
[
"Uncontrolled",
"hepatitis",
"B",
"or",
"C",
"infection"
] |
[
2,
2,
2,
2,
2,
2
] |
NCT02487082
|
60:77:treatment,79:95:treatment,97:121:treatment,123:136:treatment,138:151:treatment,153:166:treatment,194:205:chronic_disease
|
Use of any of the following drugs that might interact with study medications (anticholinergics, systemic corticosteroids, phenobarbital, peginterferon, beta-blockers or any drug that may cause arrhythmias)
| 1
|
[
"Use",
"of",
"any",
"of",
"the",
"following",
"drugs",
"that",
"might",
"interact",
"with",
"study",
"medications",
"(",
"anticholinergics",
",",
"systemic",
"corticosteroids",
",",
"phenobarbital",
",",
"peginterferon",
",",
"beta-blockers",
"or",
"any",
"drug",
"that",
"may",
"cause",
"arrhythmias",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
0,
1,
1,
0,
1,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
2,
0
] |
NCT01434316
|
7:19:treatment
|
Prior chemotherapy
| 1
|
[
"Prior",
"chemotherapy"
] |
[
0,
1
] |
NCT02088554
|
22:43:chronic_disease
|
Patient has Grade IV Diastolic Dysfunction
| 1
|
[
"Patient",
"has",
"Grade",
"IV",
"Diastolic",
"Dysfunction"
] |
[
0,
0,
0,
0,
2,
2
] |
NCT02582775
|
,,104:113:treatment
|
Available donor per section 5: targeted MFI < 1,000 (MFI exceeding 1000 must be approved by the PI and treatment team.)
| 1
|
[
"Available",
"donor",
"per",
"section",
"5",
":",
"targeted",
"MFI",
"<",
"1,000",
"(",
"MFI",
"exceeding",
"1000",
"must",
"be",
"approved",
"by",
"the",
"PI",
"and",
"treatment",
"team",
".",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT03074474
|
29:51:treatment,
|
Subject has participated in another clinical trial within the past 30 days or is currently involved in another clinical trial
| 1
|
[
"Subject",
"has",
"participated",
"in",
"another",
"clinical",
"trial",
"within",
"the",
"past",
"30",
"days",
"or",
"is",
"currently",
"involved",
"in",
"another",
"clinical",
"trial"
] |
[
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01943851
|
34:54:treatment,56:66:treatment,74:84:treatment
|
Subjects with a prior history of stem cell transplant (autologous and/or allogeneic) are allowed
| 1
|
[
"Subjects",
"with",
"a",
"prior",
"history",
"of",
"stem",
"cell",
"transplant",
"(",
"autologous",
"and/or",
"allogeneic",
")",
"are",
"allowed"
] |
[
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
1,
0,
1,
0,
0,
0
] |
NCT02516813
|
11:19:treatment,,,84:101:treatment,102:127:treatment,
|
Extensive prior RT on ≥30% of bone marrow reserve as judged by the investigator or prior bone marrow/stem cell transplantation within 5 years before trial start
| 1
|
[
"Extensive",
"prior",
"RT",
"on",
"≥30",
"%",
"of",
"bone",
"marrow",
"reserve",
"as",
"judged",
"by",
"the",
"investigator",
"or",
"prior",
"bone",
"marrow/stem",
"cell",
"transplantation",
"within",
"5",
"years",
"before",
"trial",
"start"
] |
[
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT03186937
|
58:87:chronic_disease
|
Participants must have histologically confirmed operable triple negative breast cancer
| 1
|
[
"Participants",
"must",
"have",
"histologically",
"confirmed",
"operable",
"triple",
"negative",
"breast",
"cancer"
] |
[
0,
0,
0,
0,
0,
0,
2,
2,
2,
2
] |
NCT02492867
|
37:49:treatment
|
Patients cannot tolerate concurrent chemotherapy
| 1
|
[
"Patients",
"can",
"not",
"tolerate",
"concurrent",
"chemotherapy"
] |
[
0,
0,
0,
0,
0,
1
] |
NCT01625923
|
24:35:chronic_disease
|
Subject has pronounced dehydration
| 1
|
[
"Subject",
"has",
"pronounced",
"dehydration"
] |
[
0,
0,
0,
2
] |
NCT02555189
|
35:56:treatment,35:48:treatment,64:73:treatment,75:87:treatment,89:99:treatment,
|
Patients on long term (>6 months) anti-androgen therapy (e.g., flutamide, bicalutamide, nilutamide) will need to be off anti-androgen for 4 weeks (wash out period) and show evidence of disease progression off the anti-androgen. Patients that have been on an anti-androgen 6 months or less will need to discontinue anti-androgen therapy prior to enrollment (no wash out period required)
| 1
|
[
"Patients",
"on",
"long",
"term",
"(",
">",
"6",
"months",
")",
"anti-androgen",
"therapy",
"(",
"e.g.",
",",
"flutamide",
",",
"bicalutamide",
",",
"nilutamide",
")",
"will",
"need",
"to",
"be",
"off",
"anti-androgen",
"for",
"4",
"weeks",
"(",
"wash",
"out",
"period",
")",
"and",
"show",
"evidence",
"of",
"disease",
"progression",
"off",
"the",
"anti-androgen",
".",
"Patients",
"that",
"have",
"been",
"on",
"an",
"anti-androgen",
"6",
"months",
"or",
"less",
"will",
"need",
"to",
"discontinue",
"anti-androgen",
"therapy",
"prior",
"to",
"enrollment",
"(",
"no",
"wash",
"out",
"period",
"required",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02574455
|
21:111:treatment
|
Prior exposure to a taxane (paclitaxel or docetaxel)-based regimen in localized or advanced/metastatic setting
| 1
|
[
"Prior",
"exposure",
"to",
"a",
"taxane",
"(",
"paclitaxel",
"or",
"docetaxel",
")",
"-based",
"regimen",
"in",
"localized",
"or",
"advanced/metastatic",
"setting"
] |
[
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0
] |
NCT02540330
|
14:26:allergy_name
|
Allergies to imaging dyes
| 1
|
[
"Allergies",
"to",
"imaging",
"dyes"
] |
[
0,
0,
4,
4
] |
NCT00799864
|
31:78:chronic_disease
|
Has diagnosed with documented human immuno deficiency virus (HIV-1) infection
| 1
|
[
"Has",
"diagnosed",
"with",
"documented",
"human",
"immuno",
"deficiency",
"virus",
"(",
"HIV-1",
")",
"infection"
] |
[
0,
0,
0,
0,
2,
2,
2,
2,
2,
2,
0,
0
] |
NCT02515110
|
1:23:treatment
|
Bilateral oophorectomy
| 1
|
[
"Bilateral",
"oophorectomy"
] |
[
1,
1
] |
NCT02166190
|
1:11:cancer
|
metastatic disease
| 1
|
[
"metastatic",
"disease"
] |
[
3,
0
] |
NCT02890979
|
12:28:chronic_disease
|
ongoing or active infection
| 1
|
[
"ongoing",
"or",
"active",
"infection"
] |
[
0,
0,
2,
2
] |
NCT02780401
|
1:39:chronic_disease
|
Symptomatic restrictive cardiomyopathy
| 1
|
[
"Symptomatic",
"restrictive",
"cardiomyopathy"
] |
[
2,
2,
2
] |
NCT01918683
|
45:49:treatment,64:70:cancer,75:99:treatment
|
Meets clinical criteria for eligibility for TACE to the target lesion per Interventional Radiology
| 1
|
[
"Meets",
"clinical",
"criteria",
"for",
"eligibility",
"for",
"TACE",
"to",
"the",
"target",
"lesion",
"per",
"Interventional",
"Radiology"
] |
[
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
3,
0,
1,
1
] |
NCT03072238
|
1:21:treatment
|
Radiopharmaceuticals for the purpose of imaging are permitted
| 1
|
[
"Radiopharmaceuticals",
"for",
"the",
"purpose",
"of",
"imaging",
"are",
"permitted"
] |
[
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT00734877
|
7:17:cancer,
|
Prior malignancy is acceptable provided there has been no evidence of disease within the three-year interval
| 1
|
[
"Prior",
"malignancy",
"is",
"acceptable",
"provided",
"there",
"has",
"been",
"no",
"evidence",
"of",
"disease",
"within",
"the",
"three-year",
"interval"
] |
[
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02950337
|
1:30:treatment,
|
post-operative predicted FEV1<30% predicted
| 1
|
[
"post-operative",
"predicted",
"FEV1",
"<",
"30",
"%",
"predicted"
] |
[
1,
1,
1,
0,
0,
0,
0
] |
NCT01894061
|
67:83:chronic_disease
|
Patients with impaired cardiac function or clinically significant cardiac diseases
| 1
|
[
"Patients",
"with",
"impaired",
"cardiac",
"function",
"or",
"clinically",
"significant",
"cardiac",
"diseases"
] |
[
0,
0,
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT03125226
|
,,72:91:treatment
|
Unable to have TraceIT hydrogel placement < 8 weeks prior to beginning radiation treatment
| 1
|
[
"Unable",
"to",
"have",
"TraceIT",
"hydrogel",
"placement",
"<",
"8",
"weeks",
"prior",
"to",
"beginning",
"radiation",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT00492778
|
28:44:treatment,46:52:treatment,57:78:treatment
|
Patients who have received previous vaginal, pelvic, or abdominal irradiation
| 1
|
[
"Patients",
"who",
"have",
"received",
"previous",
"vaginal",
",",
"pelvic",
",",
"or",
"abdominal",
"irradiation"
] |
[
0,
0,
0,
0,
1,
1,
0,
1,
0,
0,
1,
1
] |
NCT02207465
|
1:18:cancer
|
In-situ carcinoma is allowed
| 1
|
[
"In-situ",
"carcinoma",
"is",
"allowed"
] |
[
3,
3,
0,
0
] |
NCT02809677
|
23:39:chronic_disease,43:56:chronic_disease,60:84:chronic_disease
|
depression as part of bipolar disorder or schizophrenia or schizoaffective disorder
| 1
|
[
"depression",
"as",
"part",
"of",
"bipolar",
"disorder",
"or",
"schizophrenia",
"or",
"schizoaffective",
"disorder"
] |
[
0,
0,
0,
0,
2,
2,
0,
2,
0,
2,
2
] |
NCT02390752
|
46:55:chronic_disease
|
Subjects who are wheelchair bound because of paralysis will be considered ambulatory when they are up in their wheelchair
| 1
|
[
"Subjects",
"who",
"are",
"wheelchair",
"bound",
"because",
"of",
"paralysis",
"will",
"be",
"considered",
"ambulatory",
"when",
"they",
"are",
"up",
"in",
"their",
"wheelchair"
] |
[
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02535286
|
1:27:chronic_disease,51:78:chronic_disease,82:85:chronic_disease
|
Active autoimmune disorder (with the exception of autoimmune hemolytic anemia or ITP)
| 1
|
[
"Active",
"autoimmune",
"disorder",
"(",
"with",
"the",
"exception",
"of",
"autoimmune",
"hemolytic",
"anemia",
"or",
"ITP",
")"
] |
[
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0
] |
NCT02302235
|
26:41:treatment
|
Planned continued use of glucocorticoids
| 1
|
[
"Planned",
"continued",
"use",
"of",
"glucocorticoids"
] |
[
0,
0,
0,
0,
1
] |
NCT01572480
|
37:47:treatment,59:69:treatment,71:98:treatment,100:123:treatment,128:137:treatment,153:160:treatment
|
Contraindication to any concomitant medication, including antivirals, anticoagulation prophylaxis, tumor lysis prophylaxis, or hydration given prior to therapy
| 1
|
[
"Contraindication",
"to",
"any",
"concomitant",
"medication",
",",
"including",
"antivirals",
",",
"anticoagulation",
"prophylaxis",
",",
"tumor",
"lysis",
"prophylaxis",
",",
"or",
"hydration",
"given",
"prior",
"to",
"therapy"
] |
[
0,
0,
0,
0,
1,
0,
0,
1,
0,
1,
1,
0,
1,
1,
1,
0,
0,
1,
0,
0,
0,
1
] |
NCT02989974
|
30:41:cancer
|
Caregiver of a participating lung cancer survivor
| 1
|
[
"Caregiver",
"of",
"a",
"participating",
"lung",
"cancer",
"survivor"
] |
[
0,
0,
0,
0,
3,
3,
0
] |
NCT01734512
|
20:23:chronic_disease
|
A known history of HIV seropositivity
| 1
|
[
"A",
"known",
"history",
"of",
"HIV",
"seropositivity"
] |
[
0,
0,
0,
0,
2,
0
] |
NCT02536794
|
23:35:treatment
|
Patients who have had chemotherapy
| 1
|
[
"Patients",
"who",
"have",
"had",
"chemotherapy"
] |
[
0,
0,
0,
0,
1
] |
NCT01941316
|
86:96:treatment,132:147:allergy_name,152:172:allergy_name,174:189:allergy_name,238:247:chronic_disease,251:269:chronic_disease
|
Must have no contraindication to any of the required concomitant drugs or supportive treatments, including hypersensitivity to all anticoagulation and antiplatelet options, antiviral drugs, or intolerance to hydration due to preexisting pulmonary or cardiac impairment
| 1
|
[
"Must",
"have",
"no",
"contraindication",
"to",
"any",
"of",
"the",
"required",
"concomitant",
"drugs",
"or",
"supportive",
"treatments",
",",
"including",
"hypersensitivity",
"to",
"all",
"anticoagulation",
"and",
"antiplatelet",
"options",
",",
"antiviral",
"drugs",
",",
"or",
"intolerance",
"to",
"hydration",
"due",
"to",
"preexisting",
"pulmonary",
"or",
"cardiac",
"impairment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
4,
0,
4,
4,
0,
4,
4,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
2
] |
NCT01434316
|
7:19:treatment
|
Prior chemotherapy
| 1
|
[
"Prior",
"chemotherapy"
] |
[
0,
1
] |
NCT01666080
|
1:4:chronic_disease
|
HIV positive
| 1
|
[
"HIV",
"positive"
] |
[
2,
0
] |
NCT02122081
|
1:17:chronic_disease
|
HIV seropositive
| 1
|
[
"HIV",
"seropositive"
] |
[
2,
2
] |
NCT01956084
|
16:19:chronic_disease
|
Donors who are HIV positive
| 1
|
[
"Donors",
"who",
"are",
"HIV",
"positive"
] |
[
0,
0,
0,
2,
0
] |
NCT02159560
|
1:9:chronic_disease
|
Delirium
| 1
|
[
"Delirium"
] |
[
2
] |
NCT02339233
|
1:14:chronic_disease
|
pressure sore that might interfere with training
| 1
|
[
"pressure",
"sore",
"that",
"might",
"interfere",
"with",
"training"
] |
[
2,
2,
0,
0,
0,
0,
0
] |
NCT01850758
|
1:35:chronic_disease
|
Symptomatic lumbar spine pathology (e.g. radicular pain)
| 1
|
[
"Symptomatic",
"lumbar",
"spine",
"pathology",
"(",
"e.g",
".",
"radicular",
"pain",
")"
] |
[
2,
2,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02514070
|
51:73:chronic_disease
|
Subject must be healthy, with no known history of cardiovascular disease
| 1
|
[
"Subject",
"must",
"be",
"healthy",
",",
"with",
"no",
"known",
"history",
"of",
"cardiovascular",
"disease"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02159560
|
1:13:chronic_disease
|
Chronic pain
| 1
|
[
"Chronic",
"pain"
] |
[
2,
2
] |
NCT02501733
|
22:52:treatment
|
Patients requiring a primary total knee replacement
| 1
|
[
"Patients",
"requiring",
"a",
"primary",
"total",
"knee",
"replacement"
] |
[
0,
0,
0,
1,
1,
1,
1
] |
NCT03028298
|
1:29:treatment,
|
Pre-ictal sildenafil therapy (last dose within 1 week of presentation)
| 1
|
[
"Pre-ictal",
"sildenafil",
"therapy",
"(",
"last",
"dose",
"within",
"1",
"week",
"of",
"presentation",
")"
] |
[
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.